Citigroup Maintains Neutral on AMETEK, Raises Price Target to $263
Citigroup analyst Andrew Kaplowitz maintains AMETEK (NYSE:AME) with a Neutral and raises the price target from $261 to $263.
Stocks · News reference
Major M&A deals this week include: The Descartes Systems buys Tai, KKR nabs Ci FLAVORS, Skimmer Acquires Pool Builder Geek and Poologics.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Citigroup analyst Andrew Kaplowitz maintains AMETEK (NYSE:AME) with a Neutral and raises the price target from $261 to $263.
Baird analyst Quinn Fredrickson maintains AMETEK (NYSE:AME) with a Neutral and raises the price target from $275 to $280.
The global veterinary ophthalmology equipment market is expected to grow from USD 0.57 billion in 2026 to USD 0.83 billion by 2031, at a 7.7% CAGR. Growth is driven by rising pet ownership, increased prevalence of animal eye diseases, and adoption of advanced diagnostic and surgical technologies. Treatment applications and surgical equipment segments are leading growth, with Asia Pacific emerging as the fastest-growing region.
NASA is seeking proposals for a lunar base power system, including a Stirling radioisotope generator. Ametek's subsidiary Sunpower has already developed and proven a working prototype for NASA that has operated for over 17 years, positioning the company well to win this contract and leverage the technology for future space missions.
The global cyber warfare market is projected to grow from USD 14.99 billion in 2026 to USD 28.75 billion by 2031, with a CAGR of 14.1%. Growth is driven by increasing cyber threats to military networks, AI-driven defense solutions, space-based security demands, and defensive cyber operations. The Middle East is positioned for the second-highest regional growth rate.